Motif Bio (MTFB) Getting Somewhat Positive News Coverage, Report Shows

News stories about Motif Bio (NASDAQ:MTFB) have trended somewhat positive on Sunday, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Motif Bio earned a news impact score of 0.20 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.9225233690989 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Motif Bio (NASDAQ:MTFB) opened at $11.00 on Friday. Motif Bio has a one year low of $5.36 and a one year high of $13.75.

MTFB has been the subject of a number of recent analyst reports. Seaport Global Securities reaffirmed a “buy” rating on shares of Motif Bio in a research note on Friday, December 22nd. HC Wainwright upped their price objective on Motif Bio from $25.00 to $32.00 and gave the stock a “buy” rating in a research note on Wednesday, October 4th. Finally, WBB Securities initiated coverage on Motif Bio in a research note on Friday, December 29th. They issued a “sell” rating and a $7.00 price objective for the company.

TRADEMARK VIOLATION WARNING: “Motif Bio (MTFB) Getting Somewhat Positive News Coverage, Report Shows” was originally reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at

Insider Buying and Selling by Quarter for Motif Bio (NASDAQ:MTFB)

Receive News & Ratings for Motif Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motif Bio and related companies with's FREE daily email newsletter.

Leave a Reply